deltatrials
Completed OBSERVATIONAL NCT01077856

GARDASIL™ Vaccine Impact in Population Study (V501-033) (VIP)

GARDASIL™ Vaccine Impact in Population Study

Sponsor: Danish Cancer Society

Conditions Human Papillomavirus Infections
Updated 16 times since 2017 Last updated: Aug 24, 2022 Started: May 29, 2007 Primary completion: Dec 2, 2014 Completion: Dec 2, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Human Papillomavirus Infections, this trial is completed. The trial is conducted by Danish Cancer Society and has accumulated 16 data snapshots since 2007. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2017 · 4 months · monthly snapshot~Jun 2017 – ~Aug 2017 · 2 months · monthly snapshot~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Nov 2020 · 29 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Jun 2022 · 6 months · monthly snapshot~Jun 2022 – ~Sep 2022 · 3 months · monthly snapshot~Sep 2022 – ~Dec 2022 · 3 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshot

Change History

16 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2023 — Jul 2024 [monthly]

    Completed

  4. Dec 2022 — Jan 2023 [monthly]

    Completed

  5. Sep 2022 — Dec 2022 [monthly]

    Completed

▶ Show 11 earlier versions

  1. Jun 2022 — Sep 2022 [monthly]

    Completed

  2. Dec 2021 — Jun 2022 [monthly]

    Completed

  3. Jan 2021 — Dec 2021 [monthly]

    Completed

  4. Nov 2020 — Jan 2021 [monthly]

    Completed

  5. Jun 2018 — Nov 2020 [monthly]

    Completed

  6. May 2018 — Jun 2018 [monthly]

    Completed

  7. Apr 2018 — May 2018 [monthly]

    Completed

    Phase: NA → None

  8. Aug 2017 — Apr 2018 [monthly]

    Completed NA

  9. Jun 2017 — Aug 2017 [monthly]

    Completed NA

  10. Feb 2017 — Jun 2017 [monthly]

    Completed NA

  11. Jan 2017 — Feb 2017 [monthly]

    Completed NA

    First recorded

May 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Danish Cancer Society
  • Karolinska Institutet
  • Merck Sharp & Dohme LLC
  • Norwegian Institute of Public Health
  • Union for International Cancer Control
Data source: Merck Sharp & Dohme LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.